- Fund Type: ETC
- Objective: Sector Fund-Health & Biotech
- Asset Class: Equity
- Geographic Focus: U.S.
Tachlit Nasdaq BioTech
+ Add to WatchlistTCNBI8:IT
6,410.0000 ILs 114.0000 1.75%As of 09:24:40 ET on 05/23/2013.
Snapshot for Tachlit Nasdaq BioTech (TCNBI8)
| Open: | 6,461.0000 | High - Low: | 6,461.0000 - 6,349.0000 | Primary Exchange: | Tel Aviv |
|---|---|---|---|---|---|
| Volume: | 22,068 | 52-Week Range: | 4,504.0000 - 6,691.0000 | Beta vs CXBT: | 0.6413 |
Fund Profile & Information for TCNBI8
Tachlit NASDAQ Biotechnology is an Exchange Traded Certificate listed and traded on the TASE (Tel-Aviv Stock Exchange). This Certificate accurately replicates the performance of the NASDAQ Biotechnology Index. The Investor is entitled to exercise the Certificate on a daily basis.
| Inception Date: | 2006-02-09 | Telephone: | 972 (0)3 611 0478 Tel |
|---|---|---|---|
| Managers: | - | ||
| Web Site: | www.tih.co.il | ||
Fundamentals for TCNBI8
| NAV | (on 2011-08-15) 3,240.5300 |
|---|---|
| Assets (M) | - |
| Shares out (M) | 13.51 |
| Market Cap (M) | 866.22 |
| % Premium | - |
| Average 52-Week % Premium | - |
| Fund Leveraged | N |
Dividends for TCNBI8
| Dividend Type | Omitted |
|---|---|
| Dividend Frequency | Irreg |
| Last Dividend Net | - |
| Dividend Yield (ttm) | 0.19% |
Performance for TCNBI8
| 1-Month | +4.06% | 1-Year | +39.49% |
|---|---|---|---|
| 3-Month | +24.03% | 3-Year | +28.53% |
| Year To Date | +31.85% | 5-Year | +20.09% |
| Expense Ratio | 1.00 |
Top Fund Holdings for TCNBI8
Holding Data Unavailable.
Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
- 1
- 2
- 3
- 4
- 5
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page